Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroprotective effects of catechins in an experimental Parkinson’s disease model and SK-N-AS cells: evaluation of cell viability, anti-inflammatory and anti-apoptotic effects
Gülşen Özduran, Eda Becer, Hafize Seda Vatansever, et al.
Neurological Research (2022) Vol. 44, Iss. 6, pp. 511-523
Closed Access | Times Cited: 21

Showing 21 citing articles:

Flavonoids: Their putative neurologic roles, epigenetic changes, and gut microbiota alterations in Parkinson’s disease
Yasemin Açar, Duygu Ağagündüz, Paola De Cicco, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115788-115788
Open Access | Times Cited: 79
LINC02282 promotes DNA methylation of TRIM6 by recruiting DNMTs to inhibit the progression of Parkinson's disease
Lu Han, Chuansheng Zhao, Jin Feng, et al.
Brain Research Bulletin (2025), pp. 111224-111224
Open Access | Times Cited: 2
Chemico-biological aspects of (−)- epigallocatechin- 3 -gallate (EGCG) to improve its stability, bioavailability and membrane permeability: Current status and future prospects
Revathy Sahadevan, Satyam Singh, Anupama Binoy, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 30, pp. 10382-10411
Closed Access | Times Cited: 51
Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease
Yumin Wang, Shuang Wu, Qiang Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 46
Neurodegenerative diseases and catechins: (−)-epigallocatechin-3-gallate is a modulator of chronic neuroinflammation and oxidative stress
Siying Li, Zaoyi Wang, Gang Liu, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 12
Flavonoids as Potential Therapeutics Against Neurodegenerative Disorders: Unlocking the Prospects
Md. Faysal, Zerrouki Dehbia, Mehrukh Zehravi, et al.
Neurochemical Research (2024) Vol. 49, Iss. 8, pp. 1926-1944
Closed Access | Times Cited: 11
Combating Parkinson’s Disease with Plant-Derived Polyphenols: Targeting Oxidative Stress and Neuroinflammation
Reem M. Gahtani, Shoaib Shoaib, Umme Hani, et al.
Neurochemistry International (2024) Vol. 178, pp. 105798-105798
Closed Access | Times Cited: 10
Composition and antibacterial, anti-inflammatory, antioxidant, and anticancer activities of Rosmarinus officinalis L. essential oil
Eda Becer, Ergül Mutlu Altundağ, Mümtaz Güran, et al.
South African Journal of Botany (2023) Vol. 160, pp. 437-445
Closed Access | Times Cited: 14
Catechin Protects against Lipopolysaccharide-induced Depressive-like Behaviour in Mice by Regulating Neuronal and Inflammatory Genes
Yanfang Su, Ping Qiu, Cheng Li, et al.
Current Gene Therapy (2024) Vol. 24, Iss. 4, pp. 292-306
Closed Access | Times Cited: 4
SVHRSP protects against rotenone-induced neurodegeneration in mice by inhibiting TLR4/NF-κB-mediated neuroinflammation via gut microbiota
Mengdi Chen, Yu Zhang, Liyan Hou, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access
Alpha-Synuclein drives NURR1 and NLRP3 Inflammasome dysregulation in Parkinson's disease: From pathogenesis to potential therapeutic strategies
Ahmed M Abdelaziz
International Immunopharmacology (2025) Vol. 156, pp. 114692-114692
Closed Access
Role of Flavonoids in Protecting Against Neurodegenerative Diseases—Possible Mechanisms of Action
Elżbieta Rębas
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 10, pp. 4763-4763
Open Access
The Protection of EGCG Against 6-OHDA-Induced Oxidative Damage by Regulating PPARγ and Nrf2/HO-1 Signaling
Qi Xu, Yujie Chen, Chen Dan, et al.
Nutrition and Metabolic Insights (2024) Vol. 17
Open Access | Times Cited: 3
Effect of Flavonoids against Parkinson’s Disease
Himanshi Varshney, Yasir Hasan Siddique
Central Nervous System Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 2, pp. 145-165
Closed Access | Times Cited: 2
Natural products targeting cellular processes common in Parkinson's disease and multiple sclerosis
Xuxu Xu, Chaowei Han, Pengcheng Wang, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 6
Determination of Antioxidant Activities of Viscum album L.: First Report on Interaction of Phenolics with Survivin Protein using in silico Analysis
Safiye Elif Korcan, Nevin Çankaya, Serap Yalçın Azarkan, et al.
ChemistrySelect (2023) Vol. 8, Iss. 12
Closed Access | Times Cited: 6
Intricate subcellular journey of nanoparticles to the enigmatic domains of endoplasmic reticulum
Koyeli Girigoswami, Pragya Pallavi, Agnishwar Girigoswami
Drug Delivery (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 6
Neuroprotection induced by honey compounds
Mărgăoan Rodica, Cornea-Cipcigan Mihaiela
Elsevier eBooks (2024), pp. 1563-1586
Closed Access | Times Cited: 1
Targeting Protein Misfolding and Aggregation as a Therapeutic Perspective in Neurodegenerative Disorders
Marta Sidoryk‐Węgrzynowicz, Kamil Adamiak, Lidia Strużyńska
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12448-12448
Open Access | Times Cited: 1
Gallation and B-Ring Dihydroxylation Increase Green Tea Catechin Residence Time in Plasma by Differentially Affecting Tissue-Specific Trafficking: Compartmental Model of Catechin Kinetics in Healthy Adults
Joanna K. Hodges, Geoffrey Y. Sasaki, Yael Vodovotz, et al.
Nutrients (2023) Vol. 15, Iss. 18, pp. 4021-4021
Open Access | Times Cited: 1
A newly synthesized thiosemicarbazide derivative trigger apoptosis rather than necroptosis on HEPG2 cell line
Faika Başoğlu, Eda Becer, Hilal Kabadayı, et al.
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Open Access | Times Cited: 1
Unraveling molecular and cellular mechanisms underlying the beneficial effects of epigallocatechin-3-gallate by proteomic investigations
Sunisa Yoodee, Visith Thongboonkerd
Elsevier eBooks (2024), pp. 513-527
Closed Access
Page 1

Scroll to top